Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

11.1K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
Abnormal Proliferation02:23

Abnormal Proliferation

5.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.1K
3.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

5.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

12.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
12.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nicotinamide N-Methyl Transferase (NNMT) Sustains Innate Sensitivity to NAMPT Inhibition in YAP-dependent Stem-like/Mesenchymal Prostate Cancer.

International journal of biological sciences·2026
Same author

Collagen fibril formation at the plasma membrane occurs independently from collagen secretion.

Wellcome open research·2025
Same author

MK2 promotes p16 negative head and neck cancer migration, invasion, and metastasis.

Cancer letters·2025
Same author

Endocytic recycling is central to circadian collagen fibrillogenesis and disrupted in fibrosis.

eLife·2025
Same author

Collagen fibril formation at the plasma membrane occurs independently from collagen secretion.

bioRxiv : the preprint server for biology·2024
Same author

Collagen IV assembly is influenced by fluid flow in kidney cell-derived matrices.

Cells & development·2024

Related Experiment Video

Updated: Apr 16, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

999

IGF-Binding Protein 2 - Oncogene or Tumor Suppressor?

Adam Pickard1, Dennis J McCance1

  • 1Centre for Cancer Research and Cell Biology, Queen's University , Belfast , UK.

Frontiers in Endocrinology
|March 17, 2015
PubMed
Summary

Insulin-like growth factor binding protein 2 (IGFBP2) has a complex role in cancer, sometimes promoting tumors and other times suppressing them. This review explores factors behind IGFBP2's varied expression and function in cancer.

Keywords:
IGF-IIIGF1IGF2IGFBP2IGFBPsIGFIoncogenestumour suppressor

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.9K
Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

1.8K

Related Experiment Videos

Last Updated: Apr 16, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

999
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.9K
Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

1.8K

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Insulin-like growth factor binding protein 2 (IGFBP2) is frequently overexpressed in various cancers.
  • IGFBP2 is generally considered an oncogene, promoting tumor growth and progression.
  • Conflicting evidence suggests IGFBP2 may also exhibit tumor suppressor functions in certain contexts.

Purpose of the Study:

  • To review and analyze the contradictory roles of IGFBP2 in cancer.
  • To identify factors contributing to the variable expression and function of IGFBP2 in neoplastic diseases.
  • To provide an interpretation of IGFBP2's multifaceted involvement in tumorigenesis.

Main Methods:

  • Literature review of existing studies on IGFBP2 in cancer.
  • Analysis of in vitro and in vivo experimental data.
  • Synthesis of findings to reconcile conflicting observations.

Main Results:

  • IGFBP2 expression levels vary significantly across different cancer types and stages.
  • Both oncogenic and tumor-suppressive roles of IGFBP2 have been documented.
  • Factors such as cellular microenvironment, signaling pathways, and post-translational modifications influence IGFBP2 activity.

Conclusions:

  • The role of IGFBP2 in cancer is context-dependent and not universally oncogenic.
  • Understanding the factors influencing IGFBP2 expression and function is crucial for targeted cancer therapies.
  • Further research is needed to fully elucidate the dual nature of IGFBP2 in cancer biology.